Dallas-based ORIX USA has launched a business unit specializing in the healthcare and life sciences sectors. John Amos has been named CEO.
ORIX Health and Life Sciences will invest in operating companies within the sector and stimulate the growth of the companies through acquisitions, capital and operating assistance from ORIX USA.
“As with previous acquisitions including Houlihan Lokey, RED Capital Group and Mariner Investment Group, our interest is in businesses with strong management teams, which will be maintained as separate entities under ORIX USA’s governance and supported by our investment capital,” said ORIX USA CEO Jim Thompson in a statement. “With the launch of ORIX USA Health and Life Sciences, this strategy is broadening from financial firms to the healthcare sector.”